Sonic Healthcare (OTCMKTS:SKHHY) Hits New 12-Month Low – Time to Sell?

Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY) reached a new 52-week low on Wednesday. The stock traded as low as $12.9210 and last traded at $13.1220, with a volume of 2980 shares trading hands. The stock had previously closed at $13.03.

Analysts Set New Price Targets

Separately, Zacks Research cut Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 22nd. Two investment analysts have rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Sonic Healthcare Stock Performance

The company has a current ratio of 1.01, a quick ratio of 0.90 and a debt-to-equity ratio of 0.59. The firm has a fifty day simple moving average of $14.60 and a 200 day simple moving average of $14.29.

About Sonic Healthcare

Sonic Healthcare Limited is an Australia-based healthcare company that provides medical diagnostic services. Its principal business is laboratory medicine, including clinical pathology, anatomical pathology, genetics, and other testing services used by physicians, hospitals, and other healthcare providers. The company also offers medical imaging and related diagnostic services in selected markets.

Founded in 1987 and headquartered in Sydney, Sonic Healthcare has expanded from its Australian pathology operations into an international healthcare group.